Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 51 Infertility 22 Anovulation 11 Vitamin D Deficiency 2 Rare Diseases 2 Hyperinsulinism 2 Hyperandrogenism 2 Endocrine System Diseases 2 Prolactinoma 1 Primary Ovarian Insufficiency 1 Pathologic Processes 1 Motor Activity 1 Leiomyoma 1 Insulin Resistance 1 Infertility, Female 1 Hypogonadism 1 Hyperprolactinemia 1

Interventions

telapristone acetate 18 ulipristal acetate 17 Uterine Myomectomy 13 vilaprisan 12 Leuprolide 11 relugolix 9 estradiol, norethindrone drug combination 9 asoprisnil 9 elagolix 7 Uterine Artery Embolization 7 Mifepristone 7 Estradiol 7 Bupivacaine 7 ulipristal 6 Tranexamic Acid 6 Saline Solution 5 Norethindrone Acetate 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Letrozole 4 Hysterectomy 4 Vitamin B 6 3 Sugars 3 Misoprostol 3 Lidocaine 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Leiomyoma × Clomiphene × Clear all

NCT04177693 2023-06-05

Pharmacokinetics and Hepatic Safety of EGCG

Yale University

Phase 1 Completed

39 enrolled 18 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡